Oncolytics Biotech (ONCY) EBIT Margin (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly EBIT Margin came in at 14337.84% in Q3 2025, up 4940047.0% year-on-year from N/an in Q3 2024, and up 140.89% on a QoQ basis from 35062.63% in Q3 2024.
Oncolytics Biotech (ONCY) EBIT Margin (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 10 years of EBIT Margin data on file, last reported at 14337.84% in Q3 2025.
- On a quarterly basis, EBIT Margin rose 4940047.0% year-over-year to 14337.84% in Q3 2025; TTM through Sep 2025 was 42.67%, a 3511.0% decrease from a year earlier, with the FY2018 full-year figure at 97.36%, changed N/A from the prior year.
- EBIT Margin for Q3 2025 stood at 14337.84%, up from 35062.63% in the prior quarter.
- Over the last five years, EBIT Margin for ONCY reached as high as 14337.84% in Q3 2025 and fell as low as 35062.63% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Oncolytics Biotech | 76.93 Mn | 76.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14,337.84% |
| Sep 30, 2024 | -35,062.63% |
| Sep 30, 2020 | -16.33% |
| Jun 30, 2020 | -14.50% |
| Sep 30, 2019 | -28.18% |
| Jun 30, 2019 | -43.10% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 34.09% |
| Sep 30, 2018 | 20,877.66% |
| Jun 30, 2017 | 0.00% |
| Jun 30, 2016 | 368.32% |
| Jun 30, 2011 | 471.50% |
| Sep 30, 2010 | 2,106.77% |
| Jun 30, 2010 | -623.44% |
| Dec 31, 2009 | -5,228.79% |
| Sep 30, 2009 | 27.90% |
| Jun 30, 2009 | 36.17% |
| Mar 31, 2009 | 42.59% |